Recombinant Human Thrombopoietin Alleviates Infection-Associated Thrombocytopenia: A Retrospective Study in Senile Patients

Conclusion:
Recombinant human TPO is effective in alleviating infection-associated thrombocytopenia and hemorrhage in senile patients, particularly if given prior to the emergence of organ failure.

Source: Clinical and Applied Thrombosis/Hemostasis - November 30, 2014 Category: Hematology Authors: Lin, J., Zhu, H., Li, S., Fan, H., Lu, X. Tags: Original Articles Source Type: research